After-Hours Stock Movers 10/20: (CSX) (THC) (CNI) Higher; (ADMA) (LRCX) (AMAT) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
ADMA Biologics (ADMA) Announces Proposed $50M Stock Offering at $1/sh
October 21, 2021 9:01 AM EDTADMA Biologics, Inc. (Nasdaq: ADMA) (ADMA or the Company), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today priced its previously announced underwritten public offering of 50 million shares of its common stock at a public offering price of $1.00 per share, resulting in gross proceeds of approximately $50 million before deducting underwriting discounts and commissions and other estimated offering expenses.
The offering is expected to close on October 25, 2021, subject to the satisfaction of customary closing conditions. The Company has also granted the underwriters a 30-day option to purchase up to 7.5... More
IBM (IBM) PT Lowered to $153 at BMO Capital
October 21, 2021 7:39 AM EDTBMO Capital analyst Keith Bachman lowered the price target on IBM (NYSE: IBM) to $153.00 (from $155.00) while maintaining a Market Perform rating.
The analyst commented, "We view the quarter as mixed. Cognitive revenue was weaker and we still struggle supporting guidance that... More
